• bitcoinBitcoin(BTC)$77,186.00-0.34%
  • ethereumEthereum(ETH)$2,492.01-1.87%
  • tetherTether(USDT)$1.00-0.01%
  • binancecoinBNB(BNB)$718.90-2.23%
  • rippleXRP(XRP)$1.35-1.33%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$100.67-1.31%
  • tronTRON(TRX)$0.3407870.29%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.00-1.47%
  • zcashZcash(ZEC)$1,095.77-4.41%
  • HyperliquidHyperliquid(HYPE)$78.46-2.42%
  • dogecoinDogecoin(DOGE)$0.083748-1.62%
  • RainRain(RAIN)$0.0153191.59%
  • moneroMonero(XMR)$533.240.83%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$79.96-0.81%
  • chainlinkChainlink(LINK)$11.32-2.20%
  • leo-tokenLEO Token(LEO)$9.06-0.66%
  • cardanoCardano(ADA)$0.207335-0.51%
  • stellarStellar(XLM)$0.179741-0.71%
  • Ethena USDeEthena USDe(USDE)$1.00-0.02%
  • daiDai(DAI)$1.00-0.01%
  • bitcoin-cashBitcoin Cash(BCH)$225.05-2.45%
  • USD1USD1(USD1)$1.00-0.02%
  • litecoinLitecoin(LTC)$54.260.48%
  • uniswapUniswap(UNI)$6.33-1.18%
  • CantonCanton(CC)$0.095364-2.83%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.35-1.84%
  • hedera-hashgraphHedera(HBAR)$0.0762462.17%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • avalanche-2Avalanche(AVAX)$7.41-0.30%
  • shiba-inuShiba Inu(SHIB)$0.000005-1.25%
  • nearNEAR Protocol(NEAR)$2.32-2.88%
  • suiSui(SUI)$0.72-1.39%
  • crypto-com-chainCronos(CRO)$0.058503-0.17%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.02%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • tether-goldTether Gold(XAUT)$4,345.88-0.06%
  • MemeCoreMemeCore(M)$1.15-2.05%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • okbOKB(OKB)$113.23-0.61%
  • BittensorBittensor(TAO)$235.640.39%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.14-0.12%
  • aaveAave(AAVE)$126.721.02%
  • AsterAster(ASTER)$0.701.91%
  • BitwayBitway(BTW)$0.7027.04%
  • pax-goldPAX Gold(PAXG)$4,350.89-0.08%
  • mantleMantle(MNT)$0.57-1.09%
  • World Liberty FinancialWorld Liberty Financial(WLFI)$0.0575531.07%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

CVS, Walgreens to start dispensing abortion pill this month

March 1, 2024
in Business
Reading Time: 3 mins read
A A
CVS, Walgreens to start dispensing abortion pill this month
ShareShareShareShareShare

CVS and Walgreens said they will start dispensing the abortion pill mifepristone at pharmacies in a select number of states later this month.

YOU MAY ALSO LIKE

Scott Bessent’s attempts to suppress interest rates could spark a recession

New In-N-Out Burger teased at popular Salinas mall

Officials at the two largest pharmacy chains in the US said in interviews Friday that they had received certification to dispense mifepristone under guidelines that the Food and Drug Administration issued last year, The New York Times earlier reported.

The chains initially plan to make the medication available at a select number of Walgreens pharmacies in New York, Pennsylvania, Massachusetts, California and Illinois as early as next week, a spokesperson confirmed to The Post.

“We are beginning a phased rollout in select locations to allow us to ensure quality, safety, and privacy for our patients, providers and team members,” the representative for Walgreens — which has more than 8,600 pharmacies across the US — added.

CVS and Walgreens have been certified under the Food and Drug Administration’s guidelines to start dispensing the abortion pill mifepristone out of a select number of pharmacies. REUTERS

He added that Walgreens was “not going to dispense in states where the laws are unclear” — such as in Kansas, Montana and Wyoming, where abortion laws are being challenged and are currently in limbo — in order to protect its pharmacists and staff members.

CVS, meanwhile, is making the pill accessible at all of its pharmacies across Massachusetts and Rhode Island “in the weeks ahead,” spokeswoman Amy Thibault said, per The Times.

The Rhode Island-based retailer, which boasts 400-plus pharmacies nationwide, plans to “continually monitor and evaluate changes in state laws and will dispense mifepristone in any state where it is or becomes legally permissible to do so,” Thibault confirmed in a statement to The Post.

Certified pharmacies distributing mifepristone have to ensure that their computerized systems protected the privacy of prescribers, per modifications to the FDA’s Mifepristone REMS Program. REUTERS

CVS “will expand to additional states, where allowed by law, on a rolling basis,” she added.

Still, in some states where abortion is legal, dispensing mifepristone is illegal for a pharmacist, and can only be done by doctors, or in a hospital or clinic.

Per modifications to the FDA’s Mifepristone REMS Program in January 2023, the pill — most commonly marketed under brand names Mifeprex and Korlym — “may only be dispensed by or under the supervision of a certified prescriber, or by a certified pharmacy on a prescription issued by a certified prescriber.”

Danco Laboratories manufactures Mifeprex, while Corcept Therapeutics produces Korlym.

Nevada-based GenBioPro also produces a generic mifepristone tablet.

CVS has more than 400 pharmacies nationwide, while Walgreens boasts over 8,600. Tada Images – stock.adobe.com

Walgreens was certified to sell the medication by the brand name manufacturer Danco Laboratories, and is seeking certification from GenBioPro, Engerman said. CVS was certified by GenBioPro, according to The Times.

In order to obtain that certification, CVS and Walgreens had to ensure that their computerized systems protected the privacy of prescribers — who are certified under a separate FDA program that applies to mifepristone and several dozen other medications — as well as meet other specific steps, The Times reported.

The drug — which, in some states, can be easily prescribed through telemedicine and sent to brick-and-mortar pharmacies — typically isn’t readily available, even for doctors who are eligible providers.

As the availability in retail pharmacies expands, they may become a more popular alternative, and depending on the outcome of a case the Supreme Court will hear later this month, the pharmacy option could take on more importance.

Mifepristone is the first pill in a two-drug process to terminate a pregnancy up to 70 days in duration. The same regimen is used for miscarriages. AP

Since mifepristone’s availability in retail pharmacies is expanding, the pill is expected to become a more popular abortion alternative — depending on the outcome of a case the Supreme Court will hear later this month, in which abortion critics have sued the FDA in order to have mifepristone yanked from the market in the US, according to The Times.

An appeals court ruling in that case banned the mailing of mifepristone, instead requiring in-person doctor visits in order to obtain the medication, which is used on pregnancies less than 70 days in duration.

Terminating a pregnancy with an abortion pill is a two-drug regimen: First, a patient would take mifepristone, which blocks a hormone necessary for pregnancy development, and follows it up with misoprostol between 24 and 48 hours to cause contractions that expel pregnancy tissue, per The Times.

The same regimen is also used for miscarriages.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Scott Bessent’s attempts to suppress interest rates could spark a recession
Business

Scott Bessent’s attempts to suppress interest rates could spark a recession

September 13, 2026
New In-N-Out Burger teased at popular Salinas mall
Business

New In-N-Out Burger teased at popular Salinas mall

September 12, 2026
More than 2 million sour candy bottles recalled over choking hazard
Business

More than 2 million sour candy bottles recalled over choking hazard

September 12, 2026
Mom horrified after Meta AI starts asking about her young daughters, where family lives — and allegedly digs up years-old deleted photo
Business

Mom horrified after Meta AI starts asking about her young daughters, where family lives — and allegedly digs up years-old deleted photo

September 12, 2026
Next Post
CBS showed ‘blatant’ bias against white male ‘SEAL Team’ writer: lawsuit

CBS showed 'blatant' bias against white male 'SEAL Team' writer: lawsuit

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
An Attractive ‘Mid-Size’ Foldable With Powerful Specs

An Attractive ‘Mid-Size’ Foldable With Powerful Specs

September 8, 2026
Nationwide Investor Destinations Funds Q2 2026 Commentary (Mutual Fund:NDAAX)

Nationwide Investor Destinations Funds Q2 2026 Commentary (Mutual Fund:NDAAX)

September 8, 2026
Apple Wallet Is Not The Same As Apple Pay: Here’s How They Differ

Apple Wallet Is Not The Same As Apple Pay: Here’s How They Differ

September 9, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!